These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 10734295
1. Matched unrelated bone marrow transplantation for combined immunodeficiency. Dalal I, Reid B, Doyle J, Freedman M, Calderwood S, Saunders F, Roifman CM. Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295 [Abstract] [Full Text] [Related]
2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A. Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [Abstract] [Full Text] [Related]
3. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, Abramson SL, Ritz J, Shearer WT. J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111 [Abstract] [Full Text] [Related]
4. Matched unrelated bone marrow transplant for T+ combined immunodeficiency. Roifman CM, Somech R, Grunebaum E. Bone Marrow Transplant; 2008 Jun; 41(11):947-52. PubMed ID: 18264145 [Abstract] [Full Text] [Related]
5. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR. Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786 [Abstract] [Full Text] [Related]
6. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B. Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282 [Abstract] [Full Text] [Related]
7. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion. Bunin N, Aplenc R, Iannone R, Leahey A, Grupp S, Monos D, Pierson G. Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818 [Abstract] [Full Text] [Related]
8. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation. Kline RM, Stiehm ER, Cowan MJ. Bone Marrow Transplant; 1996 Apr; 17(4):543-8. PubMed ID: 8722352 [Abstract] [Full Text] [Related]
9. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)]. Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L. Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179 [Abstract] [Full Text] [Related]
10. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency. Smogorzewska EM, Brooks J, Annett G, Kapoor N, Crooks GM, Kohn DB, Parkman R, Weinberg KI. Arch Immunol Ther Exp (Warsz); 2000 Aug; 48(2):111-8. PubMed ID: 10807052 [Abstract] [Full Text] [Related]
11. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. Lanfranchi A, Verardi R, Tettoni K, Neva A, Mazzolari E, Pennacchio M, Pasic S, Ugazio AG, Albertini A, Porta F. Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323 [Abstract] [Full Text] [Related]
12. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient]. Cavazzana-Calvo M, André-Schmutz I, Hacein-Bey S, Schindler J, Vitetta H, Dupuis S, Quartier P, Chedeville G, Vilmer E, Casanova JL, Buffet R, Caillat-Zucman S, Radford I, Le Deist F, Fischer A. J Soc Biol; 2001 Nov; 195(1):65-8. PubMed ID: 11530503 [Abstract] [Full Text] [Related]
14. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ. Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456 [Abstract] [Full Text] [Related]
15. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning. Torjemane L, Ladeb S, Ben Othman T, Abdelkefi A, Lakhal A, Ben Abdeladhim A. Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862 [Abstract] [Full Text] [Related]
16. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID). Dickinson AM, Reid MM, Abinun M, Peak J, Brigham K, Dunn J, Cant AJ. Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241 [Abstract] [Full Text] [Related]
20. Comparison of the outcomes of allogeneic bone marrow transplantation from partially mismatched related donors, matched sibling donors, and matched unrelated donors in Japanese pediatric patients: a single center result. Nagatoshi Y, Kawano Y, Okamura J. Pediatr Transplant; 2004 Jun; 8(3):260-6. PubMed ID: 15176964 [Abstract] [Full Text] [Related] Page: [Next] [New Search]